Medecision Awarded NCQA Disease Management Systems Recertification

James Coates James Coates
VP, Marketing Services

AerialTM Platform Recognized by Leading Quality Assurance Organization for Disease Management

WAYNE, PA–Nov. 9, 2016 Medecision, the leader in population health management for risk-bearing healthcare organizations, today announced it has received Disease Management (DM) Systems Certification recertification for 17 of its disease-management programs from the National Committee for Quality Assurance (NCQA). The certification, which runs through 2018, recognizes companies and systems that excel in the design of clinical information systems that support the management of the most complex, costly and high-risk patient populations.

The NCQA disease management certification supports value-based care initiatives by allowing risk-bearing entities to proactively, effectively and efficiently manage patient populations that require the costliest care. NCQA is an independent, not-for-profit organization dedicated to measuring the quality of America’s healthcare. Certification is awarded to organizations whose products and services meet strict standards built on NCQA’s years of accreditation and certification experience, detailed market research, and input from industry experts and other stakeholders.

Disease management, executed through population health management programs, is becoming increasingly important because one in four U.S. adults now has two or more chronic health conditions, resulting in 86 percent of national healthcare costs. Additionally, spending on chronic disease represents an even greater proportion of publicly funded programs, accounting for 99 percent of Medicare spending and 83 percent of Medicaid spending. The certification of the AerialTM platform shows how the solution’s depth and breadth helps healthcare organizations directly impact complex disease states, such as congestive heart failure, high-risk pregnancy, hypertension, diabetes and obesity.

“At Medecision, we’re building solutions to change our industry’s path toward unsustainable chronic care costs—a projected increase to $4.2 trillion in treatment cost and lost economic output within 5-7 years. We’re on the forefront of this important issue, integrating analytics and workflows to prevent chronic conditions from progressing and to better treat those that do progress,” said Deborah Gage, president and CEO at Medecision. “This certification showcases success in an important part of this mission as we collaborate with our large and growing client base toward smarter financial and clinical risk management, reimbursement optimization and improved outcomes for the sickest populations.”

Leave a Reply

Your email address will not be published. Required fields are marked *